Description: The industry sees extreme value in predictive modeling and its ability to help us meet customer demands and remain profitable, but do customers and regulators look at this as a favorable addition to our process? Hear from a dynamic panel of industry experts who will tackle a variety of issues and questions from the state of the regulatory environment to the responsibilities of the carrier.

Description: This session will discuss what is meant by 'bias' and 'fairness', the regulatory environment, how to identify and mitigate bias in models, and proper oversight and governance of model building. The session will include a case study.

Description: In this webcast, the presenter will cover mental health in insurance products. Learn about the public’s increased interest in mental health and the ways insurers can meet this demand, how we can embed such offerings in insurance and how to successfully expand mental health coverage to those in need. The second speaker will cover how cancer and the simplified issue insurance market has evolved in Korea. In this session, the speaker will share the ease of selling / onboarding, thus allowing a greater penetration of products.

Description: Get an in-depth explanation on how data scientists and actuaries can work together to battle the issues arising from big data. Join our focus on the insurance industry as a whole and look at data scientists' and actuaries' roles from the views of different areas of the industry. We will also focus on how data science can be a valuable tool for actuaries. After the session, you will be able to understand: - How developments in data science are shaping Insurance Industry practices - How data scientists can help actuaries - How data science can be used to improve analysis of industry experience

Description: To explore the main drivers of the growing force of Chinese Life Insurance Industry.

Description: Highlight the importance of assigning granular policyholder behavior assumptions to cohorts of a block that behave differently for universal life products. The case study assumption testing will focus on potential cash flow impacts of surrender, lapse and premium persistency behavior— individually and combined. The case study will be based on testing data related to typical demographics for a ULSG product and not on any specific company data.

Description: Pandemic modeling and its impact on the insurance and reinsurance business have been the subject of scrutiny during the COVID-19 pandemic. As the World Health Organization (WHO) has declared its end as a global health emergency, the focus of insurers and reinsurers turns to the possibility of future pandemics. Key to considering possible future pandemics is assessing what is needed to model pandemic risks. Our presentation will focus on providing you with the following: - The main principles around creating a well-established pandemic risk modeling framework, what they are and how you should build them into your model (As a reinsurer, this is core to our business, and we have unique global insights into performing it.) - A review of pandemic risk modeling strategies as well as an understanding of the inherent uncertainties of pandemic events - Lessons learned from COVID-19 and how we can apply them in assessing the possibility of future pandemics - An understanding of the link between future pandemic risk and the capital requirements

Description: EHRs are a source of digital health data that present both an opportunity and a challenge for insurers. These rapidly maturing data sources contain valuable insights and can create a faster, better applicant experience, but the costs can quickly add up. Listen to panelists discuss various use cases for EHRs, their protective value in relation to traditional underwriting approaches, and other considerations for expanding EHR use. We will take a look at how using EHRs could promote a smart ordering approach allowing us to be quicker and more cost effective, all while understanding the impact to mortality.

Description: Have you ever struggled to make business decisions because your internal mortality studies lack credibility? Have you ever launched a new product or initiative and wanted to understand mortality risk before claims experience emerged? This session will discuss how predictive models can help actuaries enhance their traditional mortality studies with leading mortality leading indicators to be more nimble to market demands.